Current
Neuro-Oncology


Volume 19 Number 11
30 November 2017


Home > Publications > Current Neuro-Oncology > Volume 19, Year 2017 > Number 11, 30 November






Berland M, Padovani L, Rome A, Pech-Gourg G, Figarella-Branger D, André N.
Sustained Complete Response to Metronomic Chemotherapy in a Child with Refractory Atypical Teratoid Rhabdoid Tumor: A Case Report.
Front Pharmacol. 2017 Nov 1, 2017;8:792. doi: 10.3389/fphar.2017.00792.
PMID: 29163174. Case report. ˍ




Kilburn LB, Kocak M, Baxter P, Poussaint TY, Paulino AC, McIntyre C, Lemenuel-Diot A, Lopez-Diaz C, Kun L, Chintagumpala M, Su JM, Broniscer A, Baker JN, Hwang EI, Fouladi M, Boyett JM, Blaney SM.
A pediatric brain tumor consortium phase II trial of capecitabine rapidly disintegrating tablets with concomitant radiation therapy in children with newly diagnosed diffuse intrinsic pontine gliomas.
Pediatr Blood Cancer. 2017 Nov 1, 2018;65(2):10.1002/pbc.26832. doi: 10.1002/pbc.26832. PMID: 29090526.
Interventional study. ˍ




Goel NJ, Abdullah KG, Lang SS.
Outcomes and Prognostic Factors in Pediatric Oligodendroglioma: A Population-Based Study.
Pediatr Neurosurg. 2017 Nov 2, 2018;53(1):24-35. doi: 10.1159/000481458.
PMID: 29131101. Observational study. ˍ




Balaña C, Capellades J, Pineda E, Estival A, Puig J, Domenech S, Verger E, Pujol T, Martinez-García M, Oleaga L, Velarde J, Mesia C, Fuentes R, Marruecos J, Del Barco S, Villà S, Carrato C, Gallego O, Gil-Gil M, Craven-Bartle J, Alameda F; GLIOCAT Group.
Pseudoprogression as an adverse event of glioblastoma therapy.
Cancer Med. 2017 Nov 3, 2017;6(12):2858-2866. doi: 10.1002/cam4.1242. PMID: 29105360.
Observational study. ˍ




Yao Q, Cai G, Yu Q, Shen J, Gu Z, Chen J, Shi W, Shi J.
IDH1 mutation diminishes aggressive phenotype in glioma stem cells.
Int J Oncol. 2017 Nov 3,
2018;52(1):270-278. doi: 10.3892/ijo.2017.4186. PMID: 29115585. Laboratotory investigation. ˍ




Branzoli F, Di Stefano AL, Capelle L, Ottolenghi C, Valabrègue R, Deelchand DK, Bielle F, Villa C, Baussart B, Lehéricy S, Sanson M, Marjanska M.
Highly specific determination of IDH status using edited in vivo magnetic resonance spectroscopy.
Neuro Oncol. 2017 Nov 6,
2018;20(7):907-916. doi: 10.1093/neuonc/nox214. PMID: 29126125. Interventional study. ˍ




Chinnaiyan P, Won M, Wen PY, Rojiani AM, Werner-Wasik M, Shih HA, Ashby LS, Yu HM, Stieber VW, Malone SC, Fiveash JB, Mohile NA, Ahluwalia MS, Wendland MM, Stella PJ, Kee AY, Mehta MP.
A randomized phase II study of everolimus in combination with chemoradiation in newly diagnosed glioblastoma: Results of NRG Oncology RTOG 0913.
Neuro Oncol. 2017 Nov 6, 2018;20(5):666-67. doi: 10.1093/neuonc/nox209. PMID: 29126203.
Interventional study. ˍ



.

Zhao Y, Chen J, Dai X, Cai H, Ji X, Sheng Y, Liu H, Yang L, Chen Y, Xi D, Sheng M, Xue Y, Shi J, Liu J, Li X, Dong J.
Human glioma stem-like cells induce malignant transformation of bone marrow mesenchymal stem cells by activating TERT expression.
Oncotarget. 2017 Nov 6, 2027;8(61):104418-104429. doi: 10.18632/oncotarget.22301.
PMID: 29262650. Laboratotory investigation. ˍ




Garcia-Martinez A, Alenda C, Irles E, Ochoa E, Quintanar T, Rodriguez-Lescure A, Soto JL, Barbera VM.
Lack of cytomegalovirus detection in human glioma.
Virol J. 2017 Nov 7, 2017;14(1):216. doi: 10.1186/s12985-017-0885-3.
PMID: 29116009. Laboratotory investigation. ˍ




Lévy S, Chapet S, Scher N, Debbi K, Ruffier A, Bernadou G, Pointreau Y, Calais G.
Reirradiation of gliomas under stereotactic conditions: Prognostic factors for survival without relapse or side effects, a retrospective study at Tours regional university hospital (France).
Cancer Radiother. 2017 Nov 8, 2017;21(8):759-765. doi: 10.1016/j.canrad.2017.05.006.
PMID: 29128197. Observational study. ˍ




Ma TM, Grimm J, McIntyre R, Anderson-Keightly H, Kleinberg LR, Hales RK, Moore J, Vannorsdall T, Redmond KJ.
A prospective evaluation of hippocampal radiation dose volume effects and memory deficits following cranial irradiation.
Radiother Oncol. 2017 Nov 8. 2017;125(2):234-240. doi: 10.1016/j.radonc.2017.09.035.
PMID: 29128167. Interventional study. ˍ




Poh A.
Treating Recurrent Glioma with Toca 511.
Cancer Discov. 2017 Nov 8, 2018;8(1):OF8. doi: 10.1158/2159-8290.CD-NB2017-157. PMID: 29117980. Comment. ˍ
Refers to: Cloughesy TF, et al., Phase 1 trial of vocimagene amiretrorepvec and 5-fluorocytosine for recurrent high-grade glioma.
Sci Transl Med. 2016 Jun 1, 2016;8(341):341ra75. doi: 10.1126/scitranslmed.aad9784. PMID: 27252174. Interventional study. ˍ




Malmir H, Shayanfar M, Mohammad-Shirazi M, Tabibi H, Sharifi G, Esmaillzadeh A.
Tea and coffee consumption in relation to glioma: a case-control study.
Eur J Nutr. 2017 Nov 9,
2019;58(1):103-111. doi: 10.1007/s00394-017-1575-z. PMID: 29124385. Observational study. ˍ




Al-Tamimi YZ, Palin MS, Patankar T, MacMullen-Price J, O'Hara DJ, Loughrey C, Chakrabarty A, Ismail A, Roberts P, Duffau H, Goodden JR, Chumas PD.
Low-grade glioma with foci of early transformation does not necessarily require adjuvant therapy following radical surgical resection.
World Neurosurg. 2017 Nov 10,
2018;110:e346-e354. doi: 10.1016/j.wneu.2017.10.172. PMID: 29129767. Case report. ˍ




Bose R, Narang KS, Bhangale D, Kedia R, Sharma V, Jha AN.
Survival trends in glioma: Experience at a tertiary care centre.
Neurol India. 2017 Nov 10, 2017;65(6):1295-1301. doi: 10.4103/0028-3886.217968.
PMID: 29133704. Observational study. ˍ




Southwell DG, Birk HS, Han SJ, Li J, Sall JW, Berger MS.
Resection of gliomas deemed inoperable by neurosurgeons based on preoperative imaging studies.
J Neurosurg. 2017 Nov 10, 2018;129(3):567-575. doi: 10.3171/2017.5.JNS17166. PMID: 29125414. Observational study.
ˍ




Yecies D, Fisher PG, Cheshier S, Edwards M, Grant G.
Long-term outcomes of primarily metastatic juvenile pilocytic astrocytoma in children.
J Neurosurg Pediatr. 2017 Nov 10,
2018;21(1):49-53. doi: 10.3171/2017.7.PEDS17168. PMID: 29125440. Observational study / Case report. ˍ




Zou Y, Sun J, Zhou Y, Bai HX, Huang X, Babu R, Landi A, Foong KS, Zhang Z, Woo J, Tao Y, Li X, Tang X, Xiao B, Zhang P, Yang L.
Prognostic Factors and Treatment of Spinal Astrocytomas: A Multi-Institutional Cohort Analysis.
Spine (Phila Pa 1976). 2017 Nov 10,
2018;43(10):E565-E573. doi: 10.1097/BRS.0000000000002485. PMID: 29135884. Observational study. ˍ




Coburger J, Segovia von Riehm J, Ganslandt O, Wirtz CR, Renovanz M.
Is There an Indication for Intraoperative MRI in Subtotal Resection of Glioblastoma? A Multicenter Retrospective Comparative Analysis.
World Neurosurg. 2017 Nov 11,
2018;110:e389-e397. doi: 10.1016/j.wneu.2017.11.015. PMID: 29138078. Observational study. ˍ




Galuppini F, Opocher E, Tabori U, Mammi I, Edwards M, Campbell B, Kelly J, Viel A, Quaia M, Rivieri F, D'Avella D, Arcella A, Giangaspero F, Fassan M, Gardiman MP.
Concomitant IDH-wildtype glioblastoma and IDH1-mutant anaplastic astrocytoma in a patient with constitutional mismatch repair deficiency syndrome.
Neuropathol Appl Neurobiol. 2017 Nov 12, 2018;44(2):233-239. doi: 10.1111/nan.12450. PMID: 29130549. Case report. ˍ




Ghiaseddin A, Reardon D, Massey W, Mannerino A, Lipp ES, Herndon JE 2nd, McSherry F, Desjardins A, Randazzo D, Friedman HS, Peters KB.
Phase II Study of Bevacizumab and Vorinostat for Patients with Recurrent World Health Organization Grade 4 Malignant Glioma.
Oncologist. 2017 Nov 13,
2018;23(2):157-e21. doi: 10.1634/theoncologist.2017-0501. PMID: 29133513. Interventional study. ˍ




Sage W, Guilfoyle M, Luney C, Young A, Sinha R, Sgubin D, McAbee JH, Ma R, Jefferies S, Jena R, Harris F, Allinson K, Matys T, Qian W, Santarius T, Price S, Watts C.
Local alkylating chemotherapy applied immediately after 5-ALA guided resection of glioblastoma does not provide additional benefit.
J Neurooncol. 2017 Nov 14,
2018;136(2):273-280. doi: 10.1007/s11060-017-2649-8. PMID: 29139095. Observational study. ˍ




Tarasenko N, Chekroun-Setti H, Nudelman A, Rephaeli A.
Comparison of the anticancer properties of a novel valproic acid prodrug to leading histone deacetylase inhibitors.
J Cell Biochem. 2017 Nov 14,
2018;119(4):3417-3428. doi: 10.1002/jcb.26512. PMID: 29135083. Laboratory investigation. ˍ




Chen CW, Cheng TJ, Ho CH, Wang JJ, Weng SF, Hou YC, Cheng HC, Chio CC, Shan YS, Chang WT.
Increased risk of brain cancer incidence in stroke patients: a clinical case series, population-based and longitudinal follow-up study.
Oncotarget. 2017 Nov 15, 2017;8(65):108989-108999. doi: 10.18632/oncotarget.22480.
PMID: 29312585. Observational study. ˍ




Izquierdo C, Alentorn A, Idbaih A, Simó M, Kaloshi G, Ricard D, Barritault M, Meyronet D, Bruna J, Honnorat J, Delattre JY, Ducray F.
Long-term impact of temozolomide on 1p/19q-codeleted low-grade glioma growth kinetics.
J Neurooncol. 2017 Nov 15,
2018;136(3):533-539. doi: 10.1007/s11060-017-2677-4. PMID: 29143276. Observational study. ˍ




Zhao J, Zhu J, Lv X, Xing J, Liu S, Chen C, Xu Y.
Curcumin potentiates the potent antitumor activity of ACNU against glioblastoma by suppressing the PI3K/AKT and NF-κB/COX-2 signaling pathways.
Onco Targets Ther. 2017 Nov 15, 2017;10:5471-5482. doi: 10.2147/OTT.S149708.
PMID: 29180881. Laboratory investigation. ˍ




Hadi I, Roengvoraphoj O, Niyazi M, Roeder F, Schüller U, Belka C, Nachbichler SB.
Medulloblastoma in adults : A retrospective single institution analysis.
Strahlenther Onkol. 2017 Nov 16,
2018;194(3):225-234. doi: 10.1007/s00066-017-1235-5. PMID: 29147840. Observational study. ˍ




Kim S, Jing K, Shin S, Jeong S, Han SH, Oh H, Yoo YS, Han J, Jeon YJ, Heo JY, Kweon GR, Park SK, Park JI, Wu T, Lim K.
ω3-polyunsaturated fatty acids induce cell death through apoptosis and autophagy in glioblastoma cells: In vitro and in vivo.
Oncol Rep. 2017 Nov 16, 2018;39(1):239-246. doi: 10.3892/or.2017.6101.
PMID: 29192322. Laboratory investigation. ˍ




Lin AJ, Campian JL, Hui C, Rudra S, Rao YJ, Thotala D, Hallahan D, Huang J.
Impact of concurrent versus adjuvant chemotherapy on the severity and duration of lymphopenia in glioma patients treated with radiation therapy.
J Neurooncol. 2017 Nov 16,
2018;136(2):403-411. doi: 10.1007/s11060-017-2668-5. PMID: 29143923. Observational study. ˍ




Tonse R, Gupta T, Epari S, Shastri JG, Gurav M, Bano N, Jalali R.
Impact of WHO 2016 update of brain tumor classification, molecular markers and clinical outcomes in pleomorphic xanthoastrocytoma.
J Neurooncol. 2017 Nov 16,
2018;136(2):343-350. doi: 10.1007/s11060-017-2658-7. PMID: 29147864. Observational study. ˍ




Wick W, Gorlia T, Bendszus M, Taphoorn M, Sahm F, Harting I, Brandes AA, Taal W, Domont J, Idbaih A, Campone M, Clement PM, Stupp R, Fabbro M, Le Rhun E, Dubois F, Weller M, von Deimling A, Golfinopoulos V, Bromberg JC, Platten M, Klein M, van den Bent MJ.
Lomustine and Bevacizumab in Progressive Glioblastoma.
N Engl J Med. 2017 Nov 16, 2017;377(20):1954-1963. doi: 10.1056/NEJMoa1707358.
PMID: 29141164. Interventional study. ˍ




Moharamzad Y, Sanei Taheri M, Niaghi F, Shobeiri E.
Brainstem glioma: Prediction of histopathologic grade based on conventional MR imaging.
Neuroradiol J. 2017 Nov 17, 2018:1971400917743099. doi: 10.1177/1971400917743099.
PMID: 29148317. Observational study. ˍ



*

Adamski V, Hempelmann A, Flüh C, Lucius R, Synowitz M, Hattermann K, Held-Feindt J.
Dormant glioblastoma cells acquire stem cell characteristics and are differentially affected by Temozolomide and AT101 treatment.
Oncotarget. 2017 Nov 18, 2017;8(64):108064-108078. doi: 10.18632/oncotarget.22514.
PMID: 29296224. Laboratory investigation. ˍ




Harward S, Harrison Farber S, Malinzak M, Becher O, Thompson EM.
T2-weighted images are superior to other MR image types for the determination of diffuse intrinsic pontine glioma intratumoral heterogeneity.
Childs Nerv Syst. 2017 Nov 18,
2018;34(3):449-455. doi: 10.1007/s00381-017-3659-8. PMID: 29151166. Observational study. ˍ



*

Smith SJ, Diksin M, Chhaya S, Sairam S, Estevez-Cebrero MA, Rahman R.
The Invasive Region of Glioblastoma Defined by 5ALA Guided Surgery Has an Altered Cancer Stem Cell Marker Profile Compared to Central Tumour.
Int J Mol Sci. 2017 Nov 18,
2017;18(11):2452. doi: 10.3390/ijms18112452. PMID: 29156557. Laboratory investigation. ˍ




Audureau E, Chivet A, Ursu R, Corns R, Metellus P, Noel G, Zouaoui S, Guyotat J, Le Reste PJ, Faillot T, Litre F, Desse N, Petit A, Emery E, Lechapt-Zalcman E, Peltier J, Duntze J, Dezamis E, Voirin J, Menei P, Caire F, Dam Hieu P, Barat JL, Langlois O, Vignes JR, Fabbro-Peray P, Riondel A, Sorbets E, Zanello M, Roux A, Carpentier A, Bauchet L, Pallud J; Club de Neuro-Oncologie of the Société Française de Neurochirurgie.
Prognostic factors for survival in adult patients with recurrent glioblastoma: a decision-tree-based model.
J Neurooncol. 2017 Nov 20,
2018;136(3):565-576. doi: 10.1007/s11060-017-2685-4. PMID: 29159777. Observational study. ˍ




Burger MC, Breuer S, Cieplik HC, Harter PN, Franz K, Bähr O, Steinbach JP.
Bevacizumab for Patients with Recurrent Multifocal Glioblastomas.
Int J Mol Sci. 2017 Nov 20,
2017;18(11):2469. doi: 10.3390/ijms18112469. PMID: 29156610. Observational study. ˍ




Chang H, Ding Y, Wang P, Wang Q, Lin Y, Li B.
Cutaneous Metastases of the Glioma.
J Craniofac Surg. 2017 Nov 20,
2018;29(1):e94-e96. doi: 10.1097/SCS.0000000000004204. PMID: 29194279. Case report. ˍ




Lim Fat MJ, Maurice C, Maganti M, Mason WP.
Bevacizumab in Recurrent High-Grade Gliomas: A Canadian Retrospective Study.
Can J Neurol Sci. 2017 Nov 20,
2018;45(1):56-61. doi: 10.1017/cjn.2017.248. PMID: 29151389. Observational study. ˍ



*

Oushy S, Hellwinkel JE, Wang M, Nguyen GJ, Gunaydin D, Harland TA, Anchordoquy TJ, Graner MW.
Glioblastoma multiforme-derived extracellular vesicles drive normal astrocytes towards a tumour-enhancing phenotype.
Philos Trans R Soc Lond B Biol Sci. 2017 Nov 20, 2018; 373(1737): 20160477. doi: 10.1098/rstb.2016.0477.
PMID: 29158308. Laboratory investigation. ˍ




Opoku-Darko M, Amuah JE, Kelly JJP.
Surgical Resection of Anterior and Posterior Butterfly Glioblastoma.
World Neurosurg. 2017 Nov 21,
2018;110:e612-e620. doi: 10.1016/j.wneu.2017.11.059. PMID: 29162526. Observational study. ˍ




Inoue T, Endo T, Nakamura T, Shibahara I, Endo H, Tominaga T.
Expression of CD133 as a putative prognostic biomarker to predict intracranial dissemination of primary spinal cord astrocytoma.
World Neurosurg. 2017 Nov 24,
2018;110:e715-e726. doi: 10.1016/j.wneu.2017.11.089. PMID: 29180077. Observational study. ˍ




Blumenthal DT, Kanner AA, Aizenstein O, Cagnano E, Greenberg A, Hershkovitz D, Ram Z, Bokstein F.
Surgery for recurrent high grade glioma after treatment with bevacizumab.
World Neurosurg. 2017 Nov 26,
2018;110:e727-e737. doi: 10.1016/j.wneu.2017.11.105. PMID: 29183864. Observational study. ˍ




Wang WG, Ye H, Chinnaiyan P.
Practice patterns and survival outcomes of intracranial germinoma: an analysis of the National Cancer Database.
J Neurooncol. 2017 Nov 25,
2018;137(1):77-82. doi: 10.1007/s11060-017-2696-1. PMID: 29177595. Observational study. ˍ




Matsutani T, Hagiwara N, Nomura T, Fujita I, Kanazawa Y, Kakinuma D, Matsuda A, Uchida E.
Long-term survival after multidisciplinary therapy for brain metastases from asymptomatic esophageal adenocarcinoma.
Clin J Gastroenterol. 2017 Nov 27,
2018;11(2):113-117. doi: 10.1007/s12328-017-0803-7. PMID: 29181738. Case report. ˍ




Krauze AV, Peters C, Cheng J, Ning H, Mackey M, Rowe L, Cooley-Zgela T, Smart DD, Camphausen K.
Re-irradiation for recurrent glioma- the NCI experience in tumor control, OAR toxicity and proposal of a novel prognostic scoring system.
Radiat Oncol. 2017 Nov 29, 2017;12(1):191
. doi: 10.1186/s13014-017-0930-9. PMID: 29187219. Observational study. ˍ




Tamura R, Ohara K, Sasaki H, Morimoto Y, Yoshida K, Toda M.
Histopathological vascular investigation of the peritumoral brain zone of glioblastomas.
J Neurooncol. 2017 Nov 29,
2018;136(2):233-241. doi: 10.1007/s11060-017-2648-9. PMID: 29188530. Laboratory investigation. ˍ




Zetterling M, Berhane L, Alafuzoff I, Jakola AS, Smits A.
Prognostic markers for survival in patients with oligodendroglial tumors; a single-institution review of 214 cases.
PLoS One. 2017 Nov 29, 2017;12(11):e0188419
. doi: 10.1371/journal.pone.0188419. PMID: 29186201. Observational study. ˍ




Belliveau JG, Bauman GS, Macdonald D, Macdonald M, Klassen LM, Menon RS.
Apparent transverse relaxation (R2∗) on MRI as a method to differentiate treatment effect (pseudoprogression) versus progressive disease in chemoradiation for malignant glioma.
J Med Imaging Radiat Oncol. 2017 Nov 30,
2018;62(2):224-231. doi: 10.1111/1754-9485.12694. PMID: 29193849. Interventional study. ˍ




Chen JC, Koo M, Hwang JH.
Tinnitus Is Associated with a Higher Risk of Benign Brain Tumors: A Nationwide, Population-Based Secondary Cohort Study of Young and Middle-Aged Adults.
Neuroepidemiology. 2017 Nov 30, 2017;49(3-4):174-178
. doi: 10.1159/000481991. PMID: 29190632. Observational study. ˍ